Prenatal and newborn screening for CFTR mutations: the difficulties of prediction.
Regional Molecular Genetics Service, Genetic Medicine, 6th Floor, St Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK. Electronic address: martin.schwarz@nhs.net.
Martin J
MJ
Schwarz
D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D005189:False Positive Reactions; D005260:Female; D005333:Fetus; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000379:methods*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007231:Infant, Newborn; D009154:Mutation; D015997:Neonatal Screening / Q000379:methods*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods*; D017422:Sequence Analysis, DNA; D014357:Trypsin / Q000032:analysis / Q000276:immunology
D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D014357:Trypsin